InStride Health Funding: $56M Raised, Series C (2024)

InStride Health is based in Boston, MA. It has raised $56M in total funding. Latest round: Series C. Backed by General Catalyst,.406 Ventures, Valtruis.

InStride Health funding overview

InStride Health is based in Boston, MA. InStride Health has raised $56M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in January 2024. The round record for InStride Health runs through 2024; nothing later has been disclosed. Investors on record include General Catalyst, .406 Ventures, Valtruis, Mass General Brigham Ventures, Hopelab Foundation. 5 distinct backers are named across the disclosed rounds.

InStride Health at a glance

Total raised
$56M
Latest round
Series C
Latest round date
January 2024
Headquarters
Boston, MA
Notable investors
General Catalyst, .406 Ventures, Valtruis, Mass General Brigham Ventures, Hopelab Foundation

Frequently asked about InStride Health funding

How much has InStride Health raised?
InStride Health has raised $56M in total disclosed funding across the rounds on record.
Who has invested in InStride Health?
General Catalyst, .406 Ventures, Valtruis, Mass General Brigham Ventures, Hopelab Foundation are named among the investors backing InStride Health.
What was the latest InStride Health funding round?
The most recent disclosed round is a Series C, announced in January 2024.
Where is InStride Health based?
InStride Health is based in Boston, MA.
When did InStride Health last raise?
The last disclosed InStride Health round closed in January 2024 at Series C.

We update the InStride Health record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Boston and their backers are listed below.

Companies related to InStride Health (35)

Browse related funding lists (8)

Company funding database · Investor directory · Founder database · Mega-rounds 2026